Luigi Dogliotti Selected Research

Luigi Dogliotti Research Topics

Disease

25	Neoplasms (Cancer) 04/2013 - 06/2002
23	Breast Neoplasms (Breast Cancer) 05/2015 - 06/2002
11	Prostatic Neoplasms (Prostate Cancer) 04/2013 - 01/2002
7	Neoplasm Metastasis (Metastasis) 03/2007 - 01/2002
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2014 - 06/2007
4	Hypoxia (Hypoxemia) 02/2011 - 08/2006
4	Colorectal Neoplasms (Colorectal Cancer) 09/2008 - 01/2004
3	Adrenocortical Carcinoma 06/2010 - 09/2005
3	Carcinoma (Carcinomatosis) 03/2007 - 09/2002
2	Disease Progression 03/2014 - 01/2002
2	Restless Legs Syndrome (Restless Legs) 04/2013 - 05/2010
2	Transitional Cell Carcinoma 07/2007 - 07/2005
2	Osteoporosis 06/2002 - 01/2002
1	Hypertension (High Blood Pressure) 03/2014
1	Proteinuria 03/2014
1	Neutropenia 01/2013
1	Residual Neoplasm 10/2010
1	Neuroendocrine Carcinoma 11/2009
1	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 12/2008
1	Hypothyroidism 12/2008
1	Rectal Neoplasms (Rectal Cancer) 10/2007
1	Hyperplasia 02/2007
1	Bone Resorption 01/2007
1	Pathologic Complete Response 11/2005

Drug/Important Bio-Agent (IBA)

9	Epirubicin (Ellence)FDA LinkGeneric 02/2011 - 10/2002
9	Hormones (Hormone)IBA 09/2009 - 02/2003
6	Fluorouracil (Carac)FDA LinkGeneric 06/2010 - 01/2005
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2014 - 08/2006
5	AndrogensIBA 04/2013 - 01/2002
5	Tamoxifen FDA LinkGeneric 02/2011 - 08/2006
5	AnthracyclinesIBA 02/2011 - 01/2005
5	Gemcitabine FDA Link 06/2010 - 07/2002
5	Letrozole (Femara)FDA LinkGeneric 02/2009 - 09/2002
5	Estrogen ReceptorsIBA 01/2009 - 08/2006
5	Biomarkers (Surrogate Marker)IBA 11/2008 - 08/2006
5	Cisplatin (Platino)FDA LinkGeneric 07/2007 - 07/2002
4	Chromogranin AIBA 05/2010 - 02/2007
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2009 - 08/2006
4	Aromatase InhibitorsIBA 02/2009 - 04/2007
3	Vitamin D FDA LinkGeneric 03/2014 - 01/2002
3	Docetaxel (Taxotere)FDA Link 01/2013 - 04/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2011 - 03/2007
3	Biological ProductsIBA 02/2011 - 01/2011
3	Carbonic Anhydrase IXIBA 02/2011 - 09/2006
3	ErbB Receptors (EGF Receptor)IBA 01/2009 - 03/2007
3	Mitotane (Lysodren)FDA Link 12/2008 - 09/2005
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2008 - 01/2004
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2007 - 01/2002
2	Octreotide (Sandostatin)FDA LinkGeneric 03/2014 - 11/2009
2	Capecitabine (Xeloda)FDA Link 03/2014 - 06/2010
2	Pharmaceutical PreparationsIBA 01/2013 - 01/2011
2	Zoledronic Acid (Zometa)FDA Link 05/2009 - 02/2003
2	Estrogen Receptor alphaIBA 02/2009 - 01/2009
2	Proteins (Proteins, Gene)FDA Link 01/2009 - 01/2007
2	AntibodiesIBA 11/2007 - 06/2002
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2005 - 07/2005
2	Etoposide (VP 16)FDA LinkGeneric 09/2005 - 01/2005
2	CalciumIBA 09/2002 - 01/2002
1	Bevacizumab (Avastin)FDA Link 03/2014
1	danusertibIBA 01/2013
1	Antineoplastic Agents (Antineoplastics)IBA 06/2011
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 02/2011
1	EnzymesIBA 02/2011
1	Androgen Receptors (Androgen Receptor)IBA 07/2010
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2010
1	TOR Serine-Threonine KinasesIBA 01/2009
1	Caspase 3 (Caspase-3)IBA 01/2009
1	Mitogen-Activated Protein KinasesIBA 01/2009
1	Testosterone (Sustanon)FDA Link 12/2008
1	human ERBB2 proteinIBA 11/2008
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2008
1	Sirolimus (Rapamycin)FDA Link 05/2008
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2008
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2008
1	Calcitriol (Calcijex)FDA LinkGeneric 04/2008
1	Folic Acid AntagonistsIBA 02/2008
1	Thymidylate SynthaseIBA 02/2008
1	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2007
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2007
1	Leucovorin (Folinic Acid)FDA Link 10/2007
1	Prostate-Specific Antigen (Semenogelase)IBA 09/2007
1	Carboplatin (JM8)FDA LinkGeneric 07/2007
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 03/2007
1	Transforming Growth Factor alpha (TGF-alpha)IBA 03/2007
1	Messenger RNA (mRNA)IBA 01/2007
1	HGF activatorIBA 01/2007
1	Oxygen (Dioxygen)IBA 08/2006
1	Alkaline PhosphataseIBA 07/2005

Therapy/Procedure

21	Therapeutics 05/2015 - 01/2002
15	Drug Therapy (Chemotherapy) 06/2010 - 06/2002
3	Aftercare (After-Treatment) 01/2011 - 08/2006
2	Neoadjuvant Therapy 05/2015 - 08/2006
1	Radiotherapy 04/2013
1	Prostatectomy (Retropubic Prostatectomy) 04/2013
1	Castration 01/2013
1	Complementary Therapies (Alternative Medicine) 06/2011
1	Intravenous Infusions 11/2009
1	Immunomodulation 02/2009
1	Immunotherapy 02/2009
1	Palliative Care (Palliative Therapy) 10/2008